Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M 

Shigeru Kawabata, José R. Mercado-Matos, M. Christine Hollander, Danielle Donahue, Willie Wilson, Lucia Regales, Mohit Butaney, William Pao, Kwok-Kin Wong, Pasi A. Jänne, Phillip A. Dennis 

Cell Reports Volume 7, Issue 6, Pages 1824-1832 (June 2014)

DOI: 10.1016/j.celrep.2014.05.039

Copyright © 2014 The Authors Terms and Conditions

Figure 1

Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions

Figure 2

Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions

Figure 3

Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions

Figure 4

Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions

Cell Reports 2014 7, 1824-1832DOI: (10.1016/j.celrep.2014.05.039) Copyright © 2014 The Authors Terms and Conditions